Einstein Junior Phase III – 14372


Study NameStudy TitleStudy TypeSponsorSponsor Type
Einstein Junior Phase III – 14372BAY 59-7939/14372: Multicenter, open-label, active-controlled, randomized study to evaluate the efficacy and safety of an age-and body weight-adjusted rivaroxaban regimen compared to standard of care in children with acute venous thromboembolismClinical TrialBayer HealthCare AGIndustry Sponsored